Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
May 26, 2021
Product Development
Korea Spotlight: Shaking off BI setback, Bridge expands scope of BD, advances in-house therapies
James Lee-led biotech has honed its focus and begun seeking deals as far off as Europe
Read More
BioCentury
|
Apr 10, 2020
Product Development
April 9 Quick Takes: BMS tops off CAR T patent win; plus approval for Braftovi plus Erbitux, Merck, BMS, Liquidia, Circassia-AZ, Bridge
Read More
BioCentury
|
Dec 19, 2019
Finance
Boehringer deal, clinical milestones support Bridge IPO
Deal with Boehringer, pending first-in-class readouts help Bridge raise $36M in KOSDAQ IPO
Read More
BioCentury
|
Jul 18, 2019
Company News
Boehringer deal enables Bridge to expand pipeline, take in-house programs further
Read More
BioCentury
|
Apr 1, 2019
Financial News
Bridge raises $27.2M series C led by UTC, Shinhan
Read More
BioCentury
|
Dec 21, 2018
Company News
Bridge, Daewoong partner on BBT-401 for ulcerative colitis
Read More
BioCentury
|
Nov 16, 2018
Clinical News
Bridge's ulcerative colitis candidate headed for Phase II
Read More
BioCentury
|
Nov 21, 2016
Strategy
LG’s biotech legacy
How LG's shifting focus helped spawn a new biotech industry in South Korea
Read More
BioCentury
|
Oct 10, 2016
Emerging Company Profile
Pellino play
How Bridge's first program attacks inflammatory disease on multiple fronts
Read More
Items per page:
10
1 - 9 of 9